Cessatech A/S Share Price

Equities

CESSA

DK0061411964

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 28/04/2024 BST			5-day change	1st Jan Change
6.34 ^DKK	-4.23%		+2.26%	-12.67%

02-29	Cessatech A/S Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Cessatech A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Financials

Sales 2022	-	Sales 2023	-	Capitalization	100M 697M 7.98B
Net income 2022	-14M -97.54M -1.12B	Net income 2023	-26M -181M -2.07B	EV / Sales 2022	-
Net cash position 2022	23.34M 163M 1.86B	Net cash position 2023	3.37M 23.5M 269M	EV / Sales 2023	-
P/E ratio 2022	-0.78 x	P/E ratio 2023	-3.77 x	Employees	4
Yield 2022 *	-	Yield 2023	-	Free-Float	0%

More Fundamentals * Assessed data

Chart Cessatech A/S

Duration

Period

Style

Dynamic Chart

Latest news about Cessatech A/S

Cessatech A/S Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Cessatech A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-16	CI
Cessatech A/S Announces the Paediatric Committee Agrees to Reduce the Number of Required Children in the Final Clinical Study with CT001 from 300 to 150 Children	25/10/23	CI
Cessatech Announces Last Participant Dosed in Pivotal Trial 0205 with Lead Candidate CT001	21/09/23	CI
Cessatech Wins EU Nod for Clinical Studies of Nasal Sedation Spray in Children; Shares Soar 21%	12/09/23	MT
Cessatech A/S Announces EMA's Paediatric Committee Agrees to Paediatric Investigational Plan for CT002 for Procedural Sedation	12/09/23	CI
Cessatech A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23	CI
Cessatech A/S Secures DKK 5 Million Loan Facility Agreement to Support the US Launch of its Lead Program CT001	17/08/23	CI
Cessatech A/S and Ventis Pharma Announce US Partnership for CT001	27/06/23	CI
Cessatech A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	29/04/23	CI
Cessatech A/S Appoints Martin Olin as the Chairman of the Board	23/03/23	CI
Cessatech A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	01/03/23	CI
Cessatech A/S Reports Earnings Results for the Full Year Ended December 31, 2022	28/02/23	CI
Cessatech A/S Auditor Raises 'Going Concern' Doubt	27/02/23	CI
Cessatech A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	18/11/22	CI

More news

Press releases Cessatech A/S

A short business update	04-18	AQ
Minutes from the Annual General Meeting in Cessatech A/S	03-27	AQ
Annual General Meeting - 27 March 2024	03-11	AQ
Cessatech A/S publishes Annual Report for the fiscal year 2023	02-29	AQ
CESSATECH ANNOUNCES RESULT OF WARRANT EXERCISE FOR WARRANTS OF SERIES TO2	01-30	AQ